We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Votes to Hasten Generic Pricing, Leaves New Drug Timelines Alone
EU Votes to Hasten Generic Pricing, Leaves New Drug Timelines Alone
February 11, 2013
The European Parliament voted overwhelmingly in favor of a draft law that would require member states to decide on the pricing and reimbursement of generic medicines within 60 days of an application.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor